CLINICAL_TRIALS
trial_result
· 2014-07-22
Clinical Trial Update: Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol [Phase 4]
Summary
Phase 4 trial investigating metoprolol to prevent anthracycline or trastuzumab-induced cardiomyopathy; study terminated with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Cardiomyopathy | Phase 4 | Status: TERMINATED | Results posted: 2014-07-22